Metraipolis › archive › dc_899c859086fc

A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies — Europe PMC PMID:41162386

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41162386
DOI
10.1038/s41421-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T23:28:01.289Z
SHA-256 of the archived text
ef1be5b0e25471627a41d5cca2c6ff752eaddec977e9a1795869f0327e3cc560
Stable URL of this page
https://metraipolis.com/documento/dc_899c859086fc

How to cite

A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies — Europe PMC PMID:41162386 — Europe PMC (en), https://europepmc.org/article/MED/41162386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_899c859086fc (Metraipolis archive dc_899c859086fc, sha256 ef1be5b0e25471627a41d5cca2c6ff752eaddec977e9a1795869f0327e3cc560)
BibTeX
@misc{dc899c859086fc,
  title = {A synergistic generative-ranking framework for tailored design of therapeutic single-domain antibodies — Europe PMC PMID:41162386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41162386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_899c859086fc; sha256 ef1be5b0e25471627a41d5cca2c6ff752eaddec977e9a1795869f0327e3cc560},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41162386. Agents can read the archived copy with the MCP tool read_document.